Northwest Biotherapeutics, Inc. (NWBO)

Northwest Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	314	358	364	822	830	663
Market Cap Growth	-19.97%	-1.53%	-55.72%	-1.00%	25.14%	-47.13%
Enterprise Value	388	444	435	881	865	686
Last Close Price	0.19	0.23	0.27	0.70	0.78	0.70
PE Ratio	-	-	-	-	-	3.70
PS Ratio	209.50	260.08	263.35	425.38	493.23	660.04
PB Ratio	-8.24	-7.53	-4.61	-17.47	-7.90	-5.35
EV/Sales Ratio	259.39	322.41	314.92	455.93	513.96	682.10
Debt / Equity Ratio	-1.68	-1.36	-0.85	-0.97	-0.25	-0.31
Net Debt / Equity Ratio	-1.63	-1.30	-0.83	-0.92	-0.18	-0.18
Net Debt / EBITDA Ratio	-1.22	-1.07	-1.01	-0.80	-0.29	-0.43
Net Debt / FCF Ratio	-1.26	-1.33	-1.12	-0.76	-0.35	-0.51
Asset Turnover	0.03	0.03	0.05	0.07	0.05	0.03
Quick Ratio	0.02	0.03	0.03	0.05	0.06	0.11
Current Ratio	0.08	0.06	0.06	0.09	0.08	0.13
Return on Assets (ROA)	-62.18%	-69.33%	-152.28%	-117.23%	-117.48%	-90.17%
Return on Capital Employed (ROCE)	1831.00%	575.50%	160.10%	320.10%	71.00%	56.30%
Earnings Yield	-14.43%	-16.79%	-23.02%	-7.62%	-12.65%	27.00%
FCF Yield	-15.75%	-12.91%	-15.95%	-6.94%	-6.71%	-6.68%
Buyback Yield / Dilution	-17.74%	-17.26%	-10.99%	-10.17%	-0.79%	-38.99%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error